Cargando…

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer

BACKGROUND: Bladder cancer (BC) is a common urinary tract system tumor with high recurrence rate and different populations show distinct response to immunotherapy. Novel biomarkers that can accurately predict prognosis and therapeutic responses are urgently needed. Here, we aim to identify a novel p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yichi, Lin, Yifeng, Lv, Daojun, Wu, Xiangkun, Li, Wenjie, Wang, Xueqing, Jiang, Dongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796709/ https://www.ncbi.nlm.nih.gov/pubmed/35127296 http://dx.doi.org/10.7717/peerj.12843

Ejemplares similares

Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC
por: Wang, Zemin, et al.
Publicado: (2022)

Novel pyroptosis-associated genes signature for predicting the prognosis of sarcoma and validation
por: Wen, Hao, et al.
Publicado: (2022)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma
por: Mao, Deli, et al.
Publicado: (2020)

A robust signature of immune‐related long non‐coding RNA to predict the prognosis of bladder cancer
por: Lai, Cong, et al.
Publicado: (2021)

An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma
por: Liu, Danqi, et al.
Publicado: (2020)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

Identification of Vitamin D-related gene signature to predict colorectal cancer prognosis
por: Bu, Luping, et al.
Publicado: (2021)

Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation
por: Zhao, Wenjing, et al.
Publicado: (2023)

Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation
por: Wu, Xuan, et al.
Publicado: (2023)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis
por: Xu, Dafeng, et al.
Publicado: (2020)

Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer
por: Qi, Wenqian, et al.
Publicado: (2021)

A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
por: Zhang, Jianhua, et al.
Publicado: (2023)

Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer
por: Li, Ai, et al.
Publicado: (2023)

Development and validation of a personalized classifier to predict the prognosis and response to immunotherapy in glioma based on glycolysis and the tumor microenvironment
por: Fan, Pengfei, et al.
Publicado: (2023)

Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy
por: Zhong, Shanliang, et al.
Publicado: (2020)

Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients
por: Wang, Jukun, et al.
Publicado: (2021)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients
por: Tang, Huamei, et al.
Publicado: (2020)

Hub gene associated with prognosis in bladder cancer is a novel therapeutic target
por: Fang, Dengpan, et al.
Publicado: (2023)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
por: Li, Ruowen, et al.
Publicado: (2023)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

Construction and validation of a fatty acid metabolism-related gene signature for predicting prognosis and therapeutic response in patients with prostate cancer
por: Zhao, Hongjun, et al.
Publicado: (2023)

Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer
por: Lv, Daojun, et al.
Publicado: (2021)

A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma
por: Wu, Zhengyuan, et al.
Publicado: (2021)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Identification and validation of RNA‐binding protein‐related gene signature revealed potential associations with immunosuppression and drug sensitivity in glioma
por: Chen, Zhuohui, et al.
Publicado: (2021)

Comprehensive pathway-related genes signature for prognosis and recurrence of ovarian cancer
por: Zhao, Xinnan, et al.
Publicado: (2020)

Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma
por: Shi, Yucang, et al.
Publicado: (2022)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
por: Ma, Sheng, et al.
Publicado: (2023)

Establishment of a 12-gene expression signature to predict colon cancer prognosis
por: Sun, Dalong, et al.
Publicado: (2018)

Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
por: Yang, Mingjun, et al.
Publicado: (2020)

The m(6)A-related gene signature for predicting the prognosis of breast cancer
por: Zhong, Shanliang, et al.
Publicado: (2021)

Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients
por: Cai, Jingjing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ilt3kmm6b6lv9msd6d9q2ah7b